Vascular RhoJ Is an Effective and Selective Target for Tumor Angiogenesis and Vascular Disruption-Reference-Cited by-同舟云学术

Vascular RhoJ Is an Effective and Selective Target for Tumor Angiogenesis and Vascular Disruption

Published:2014-01 Issue:1 Volume:25 Page:102-117
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Kim Chan,Yang Hanseul,Fukushima Yoko,Saw Phei Er,Lee Junyeop,Park Jin-Sung,Park Intae,Jung Jinmyung,Kataoka Hiroshi,Lee Doheon,Do Heo Won,Kim Injune,Jon Sangyong,Adams Ralf H.,Nishikawa Shin-Ichi,Uemura Akiyoshi,Koh Gou Young

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference43 articles.

1. Anticancer potential of tumor vascular disrupting agents: review of the latest clinical evidence;Baguley;Clin. Investig.,2012

2. Driving Rho GTPase activity in endothelial cells regulates barrier integrity;Beckers;Thromb. Haemost.,2010

3. Modes of resistance to anti-angiogenic therapy;Bergers;Nat. Rev. Cancer,2008

4. Inhibition of tumor angiogenesis and growth by a small-molecule multi-FGF receptor blocker with allosteric properties;Bono;Cancer Cell,2013

5. What tangled webs they weave: Rho-GTPase control of angiogenesis;Bryan;Cell. Mol. Life Sci.,2007

Cited by 115 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted delivery of nano-radiosensitizers for tumor radiotherapy;Coordination Chemistry Reviews;2024-11

2. A four-gene model for prognostic prediction in bladder urothelial carcinoma;Gene Reports;2024-09

3. Regulating Aggregation‐Induced Emission Luminogen for Multimodal Imaging‐Navigated Synergistic Therapy Involving Anti‐Angiogenesis;Advanced Science;2024-08-29

4. Inhibiting endothelial Rhoj blocks profibrotic vascular intussusception and angiocrine factors to sustain lung regeneration;Science Translational Medicine;2024-08-28

5. RhoJ: an emerging biomarker and target in cancer research and treatment;Cancer Gene Therapy;2024-06-10